Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care
-
* Corresponding author: Peter Bramlage peter.bramlage@mailbox.tu-dresden.de
BMC Cardiovascular Disorders 2008, 8:30 doi:10.1186/1471-2261-8-30
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 29 Feb 2008 | |
| Reviewer's Report | Hanke Mollnau | 02 Jun 2008 | |
| Reviewer's Report | Pablo Lapuerta | 25 Jul 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 23 Sep 2008 |
| Reviewer's Report | Pablo Lapuerta | 20 Oct 2008 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 30 Oct 2008 |
| Editorial acceptance | 30 Oct 2008 | ||
| Published | 10 Nov 2008 |